The global In Vitro Fertilization market reached an estimated USD 18.6 billion in 2025, rising from USD 9.4 billion in 2018, reflecting increasing infertility rates, delayed parenthood trends, and expanding reproductive healthcare access. The In Vitro Fertilization industry is projected to grow at a 9.7% CAGR between 2025 and 2034, eventually surpassing USD 41.8 billion by 2034. Rising fertility treatment demand, increasing awareness, and technological improvements continue to strengthen long-term market expansion.
Globally, infertility affects nearly 17.5% of adults, equivalent to approximately 1 in 6 couples, increasing demand for In Vitro Fertilization procedures. More than 3.4 million IVF cycles were performed worldwide in 2024, compared to 1.9 million procedures in 2015, reflecting a 79% increase over nine years. Growing healthcare investments and insurance coverage expansion are accelerating market accessibility.
Historical Market Growth and Revenue Performance (2015–2025)
The In Vitro Fertilization market showed strong progression over the past decade. In 2015, global market valuation stood near USD 7.2 billion, increasing to USD 7.9 billion in 2016 and USD 8.6 billion in 2017. By 2018, the market reached USD 9.4 billion, supported by rising clinic expansion.
In 2019, revenue climbed to USD 10.3 billion, reflecting 9.6% year-over-year growth. Despite healthcare disruptions in 2020, the market maintained resilience at USD 10.8 billion. Recovery accelerated with USD 12.5 billion in 2021, USD 14.1 billion in 2022, USD 16.4 billion in 2023, USD 17.8 billion in 2024, and USD 18.6 billion in 2025.
Year-over-Year Procedure Growth and Fertility Trends
The In Vitro Fertilization market continues to expand through increasing treatment volumes. Between 2021 and 2022, IVF cycles increased by 12.8% globally, followed by 10.4% growth between 2022 and 2023. In 2024, treatment demand rose another 8.5%, supported by broader fertility awareness.
Delayed childbirth is a key factor. The average maternal age for first-time pregnancy increased from 26.8 years in 2000 to 30.4 years in 2025 across developed economies. Women aged 35–44 account for nearly 44% of IVF procedures, reflecting higher fertility intervention demand among older reproductive populations.
Regional Market Distribution and Revenue Breakdown
North America leads the In Vitro Fertilization market with 35% global revenue share in 2025, equivalent to approximately USD 6.5 billion. The United States accounts for over 78% of regional demand, supported by advanced fertility infrastructure and insurance reimbursement programs.
Europe represents 31% market share, valued at USD 5.8 billion, driven by Spain, Germany, France, and the UK. Asia-Pacific contributes 27% share, experiencing the fastest expansion at 11.4% CAGR, while Latin America and Middle East & Africa jointly hold 7% market share.
Treatment Type Segmentation and Procedure Analysis
The In Vitro Fertilization market includes fresh embryo transfer, frozen embryo transfer, donor egg IVF, intracytoplasmic sperm injection (ICSI), and genetic screening procedures. ICSI dominates with 41% procedure share, followed by frozen embryo transfer at 29%.
Frozen embryo procedures increased by 18% between 2020 and 2025, driven by higher implantation success rates. Preimplantation genetic testing usage expanded by 22% annually, improving embryo selection and reducing chromosomal abnormalities.
Globally, IVF success rates vary by age. Women under 35 experience 46–52% live birth success rates, while ages 35–37 average 36–41%, and women over 40 show 12–18% success rates per cycle.
Key Drivers Supporting In Vitro Fertilization Expansion
Infertility prevalence is increasing due to lifestyle changes, obesity, and reproductive health conditions. Male infertility contributes to nearly 40–50% of global infertility cases, increasing demand for advanced In Vitro Fertilization procedures.
Government support is another major driver. Several countries collectively allocated more than USD 6.7 billion toward fertility healthcare programs between 2020 and 2025. Public reimbursement policies increased IVF affordability by 20–35% in subsidized healthcare systems.
Rising awareness also plays a role. Online fertility consultations increased by 63% between 2021 and 2024, while fertility app usage surpassed 140 million global downloads by 2025.
Clinic Infrastructure and Industry Statistics
The In Vitro Fertilization industry operates through more than 8,500 fertility clinics worldwide. The United States alone has over 520 IVF centers, while Europe hosts approximately 2,100 specialized fertility facilities.
Large fertility networks reported annual revenue growth of 12–18% between 2022 and 2025. Private equity investment in fertility clinics exceeded USD 4.3 billion globally between 2021 and 2025, fueling expansion of multi-location treatment networks.
Leading clinics conduct between 1,500 and 8,000 IVF cycles annually, depending on facility size. High-volume centers achieve success rates 8–12% above industry averages, largely due to advanced embryo monitoring technologies.
Cost Analysis and Treatment Economics
Average In Vitro Fertilization treatment costs vary significantly by geography. In the United States, a single IVF cycle costs between USD 12,000 and USD 18,000, excluding medications. Europe averages USD 4,000–USD 8,500 per cycle, while Asia-Pacific ranges from USD 2,500–USD 7,000.
Medication contributes approximately 28–35% of total treatment costs. Genetic testing adds USD 2,000–USD 5,000 per cycle, depending on screening complexity. Despite high costs, financing programs expanded by 31% between 2022 and 2025, improving patient accessibility.
Future Market Forecast Through 2034
The In Vitro Fertilization market is expected to exceed USD 25.4 billion by 2029 and reach USD 41.8 billion by 2034. Annual IVF procedures are projected to surpass 6.2 million cycles globally by 2034, compared to 3.4 million cycles in 2024.
Asia-Pacific is expected to record the fastest growth due to fertility tourism and healthcare affordability. Fertility preservation procedures, including egg freezing, are forecast to grow at 14.6% CAGR, becoming a major adjacent segment within the In Vitro Fertilization industry.
Consumer Trends and Fertility Demographics
Women aged 30–39 account for nearly 58% of total IVF demand, reflecting delayed family planning trends. Same-sex couples and single-parent fertility treatment demand increased by 26% between 2020 and 2025.
Employer-sponsored fertility benefits expanded significantly, with 42% of Fortune 500 companies offering fertility coverage by 2025, compared to 24% in 2018. Corporate fertility benefit spending increased by 18% annually, supporting broader patient access.
Conclusion: In Vitro Fertilization Market Positioned for Long-Term Expansion
The In Vitro Fertilization market demonstrates strong growth supported by rising infertility prevalence, expanding healthcare access, and technological innovation. Increasing from USD 18.6 billion in 2025 to USD 41.8 billion by 2034, the market is projected to more than double over the forecast period.
With IVF cycles expected to exceed 6.2 million annually, fertility clinic infrastructure expanding worldwide, and treatment success rates improving steadily, the In Vitro Fertilization industry remains one of the fastest-growing segments within reproductive healthcare.
Read Full Research Study: https://marketintelo.com/report/in-vitro-fertilization-market